BNTX News and Press, BioNTech SE From 05/20/24

2024-05-20 17:17:41 ET Summary Moderna's individualized neoantigen therapy, mRNA-4157, is a cancer vaccine with potential in multiple cancer types. mRNA-4157 has produced compelling results in stage III/IV melanoma patients, where a combination with pembrolizumab reduced the risk ...

2024-05-17 13:25:19 ET More on Moderna Moderna Q1: A Promising Pipeline Is Undervalued Moderna, Inc. (MRNA) Q1 2024 Earnings Call Transcript Moderna, Inc. 2024 Q1 - Results - Earnings Call Presentation Evercore says biotech ‘winter is finally thawing&#...

MAINZ, Germany, May 17, 2024 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX, “BioNTech” or the “Company”) held its Annual General Meeting (“AGM”) today, May 17, 2024. A total of 87.51 per cent of the share capital was represented at the vir...

2024-05-14 13:02:31 ET Summary Autolus Therapeutics now has years of operational runway after recent financing. Operating expenses are manageable, with numerous pipeline projects in the hopper. Autolus likely has an approved therapy on their hands, just waiting for the Novembe...

2024-05-14 11:24:32 ET More on BioNTech, Moderna, etc. BioNTech SE 2024 Q1 - Results - Earnings Call Presentation BioNTech SE (BNTX) Q1 2024 Earnings Call Transcript Regeneron: Dissecting The First Quarter Results And Regulatory Setbacks Moderna announces del...

2024-05-10 11:15:35 ET More on Novavax Novavax Q1 2024 Earnings Preview: Success In New Commercial COVID Markets Unlikely Novavax, Inc. (NVAX) TD Cowen's 44th Annual Health Care Conference - (Transcript) Novavax: Another Day Older And Deeper In Novavax surges...

2024-05-08 07:06:13 ET More on AstraZeneca AstraZeneca: A Triple Shot Of Income, Growth, And Value AstraZeneca: Strong In A Weak Market AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript AstraZeneca invests $140M in Cellectis, raising stake to 44% ...

2024-05-06 14:30:16 ET Image source: The Motley Fool. BioNTech Se (NASDAQ: BNTX) Q1 2024 Earnings Call May 06, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: BioNTech Se (BNTX) Q1 2024 Earnings Call Transcript

2024-05-06 12:30:05 ET BioNTech SE (BNTX) Q1 2024 Earnings Conference Call May 06, 2024 08:00 AM ET Company Participants Victoria Meissner - VP, Strategy & IR Ugur Sahin - Co-Founder & CEO Ozlem Tureci - Chief Medical Officer & Co-Founder Jens Hol...

2024-05-06 11:08:32 ET More on BioNTech BioNTech: Undecided Between A One Trick Pony And A Full-Fledged Pharma Company BioNTech Earnings Preview: I Will Stay On The Sidelines BioNTech's Brew: Mixing COVID Legacy With Oncology Ambitions BioNTech Q1 2024 Earn...